A Phase 2 Open Label Study Investigating the Efficacy and Safety of Roxadustat (FG-4592) for Treatment of Anemia in Patients Receiving Chemotherapy Treatment for Non-Myeloid Malignancies
Clinical Trial Information
Trial Contact: Donaldson, Karin M; Valdez, Crystal
The purpose of this study is to find out if roxadustat (also known as FG-4592) is safe and effective for the treatment of anemia in people receiving chemotherapy treatment for cancer.
1.Diagnosis of non-myeloid malignancy
2.Anemia caused by cancer treatment (myelosuppressive chemotherapy) defined as Hb ≤10.0 g/dL at screening
3.Planned concurrent treatment of cancer with chemotherapy for at least 8 additional weeks